Terminated NA INTERVENTIONAL NCT00563485

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily in the Successful Rate of Trial Without Catheter in Acute Urinary Retention With Long Term Follow up

Sponsor: Hospital Authority, Hong Kong

Conditions Prostatic Hyperplasia Urinary Retention

Interventions Doxazosin GITS (Cardura XL) Terazosin (Hytrin)

Updated 5 times since 2017 Last updated: Jun 15, 2011 Started: Oct 31, 2005 Completion: Nov 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Hospital Authority, Hong Kong

See all terminations from Hospital Authority, Hong Kong

Other Prostatic Hyperplasia trials with similar outcome

Browse all Prostatic Hyperplasia trials

A NA clinical study on Prostatic Hyperplasia and Urinary Retention, this trial is terminated or withdrawn. The trial is conducted by Hospital Authority, Hong Kong and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Authority, Hong Kong

Data source: Hospital Authority, Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, China